International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
American Swedish Institute 1929, the "Minneapolis Tribune" reported, "the cost is believed to have been close to $1,000,000 although this is a matter the builder does not discuss." The transition from private residence to museum happened in 1929 when the family donated the house and the newspaper to establish the American Institute for Swedish Arts, Literature and Science (later changed to the American Swedish Institute). Turnblad stated that he had long planned for the home to be a Swedish-American institute. He was quoted as saying, "many persons may have wondered what a small family like ours, a family which had not great social